Keywords: nccn, gets, 5m, grant, b-ms/imclone, usa, non-profit
NCCN gets $1.5M grant from B-MS/ImClone
Article | 01 December 2008
The USA's non-profit National Comprehensive Cancer Network has been awarded a $1.5-million grant from drug major Bristol-Myers Squibb and ImClone ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
